BCMLT
WST icon

Beacon Capital Management LLC (Tennessee)’s West Pharmaceutical WST Stock Holding History

Beacon Capital Management LLC (Tennessee)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7
Closed -$1.53K – 1026
2025
Q2 		$1.53K Hold
7
– – ﹤0.01% 938
2025
Q1 		$1.57K Hold
7
– – ﹤0.01% 984
2024
Q4 		$2.29K Sell
7
-1
-13% -$315 ﹤0.01% 872
2024
Q3 		$2.4K Buy
8
+1
+14% +$306 ﹤0.01% 959
2024
Q2 		$2.31K Hold
7
– – ﹤0.01% 842
2024
Q1 		$2.77K Hold
7
– – ﹤0.01% 817
2023
Q4 		$2.63K Hold
7
– – ﹤0.01% 761
2023
Q3 		$2.68K Hold
7
– – ﹤0.01% 799
2023
Q2 		$2.68K Buy
+7
New +$2.5K ﹤0.01% 799

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Beacon Capital Management LLC (Tennessee)'s WST Position: Q3 2025 in Review

Beacon Capital Management LLC (Tennessee) sold out of West Pharmaceutical (WST) in Q3 2025, closing a stake of 7 shares — an estimated $1.53K sold.

Beacon Capital Management LLC (Tennessee) first reported a position in WST in Q2 2023 and held it in 9 quarters. The position peaked at $2.77K in Q1 2024. 756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Beacon Capital Management LLC (Tennessee) reported no remaining West Pharmaceutical position as of Q3 2025 after selling out during the quarter.
  • Beacon Capital Management LLC (Tennessee) sold 7 West Pharmaceutical shares in Q3 2025, an estimated $1.53K.
  • Beacon Capital Management LLC (Tennessee) first reported a position in West Pharmaceutical in Q2 2023 and held it in 9 quarters.
  • Beacon Capital Management LLC (Tennessee)'s West Pharmaceutical position peaked at $2.77K in Q1 2024.
  • 756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q3 2025, filed 7 Nov 2025.